Diminished HLA-DR expression on monocyte and dendritic cell subsets indicating impairment of cellular immunity in pre-term neonates: A prospective observational analysis

Journal of Perinatal Medicine

Volumn 43, Issue 5, 2015, Pages 609-618

  Schefold, Joerg C ^a,b   Porz, Linn ^b   Uebe, Barbara ^b   Poehlmann, Holger ^b   Von Haehling, Stephan ^b,c   Jung, Andreas ^b   Unterwalder, Nadine ^b   Meisel, Christian ^b  

^a UNIVERSITY OF BERN   (Switzerland)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

Author keywords

Dendritic cells; HLA DR; immunoparalysis; inflammation; monocytes; organ failure; sepsis; septic shock; severe infection

Indexed keywords

ANTIBIOTIC AGENT; CD14 ANTIGEN; CD16 ANTIGEN; HLA DR ANTIGEN;

ANTIGEN EXPRESSION; APGAR SCORE; ARTICLE; ARTIFICIAL VENTILATION; BIRTH WEIGHT; CELL SUBPOPULATION; CELLULAR DISTRIBUTION; CELLULAR IMMUNITY; CLINICAL ARTICLE; CLINICAL RISK INDEX FOR BABIES SCORE; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATIONAL STUDY; DENDRITIC CELL; DOWN REGULATION; FEMALE; FLOW CYTOMETRY; GESTATIONAL AGE; HUMAN; IMMUNE DEFICIENCY; LEUKOCYTE; LEUKOCYTE COUNT; LIMIT OF QUANTITATION; MALE; MONOCYTE; NEWBORN; OBSERVATIONAL STUDY; PREMATURITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RESPIRATORY DISTRESS; SCORING SYSTEM; SEPSIS; TREATMENT OUTCOME; ADULT; BLOOD; CLASSIFICATION; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; INFECTION; NEONATAL RESPIRATORY DISTRESS SYNDROME; PREGNANCY; YOUNG ADULT;

ADULT; DENDRITIC CELLS; FEMALE; GESTATIONAL AGE; HLA-DR ANTIGENS; HUMANS; IMMUNE TOLERANCE; IMMUNITY, CELLULAR; INFANT, NEWBORN; INFANT, PREMATURE; INFECTION; MALE; MONOCYTES; PREGNANCY; PROSPECTIVE STUDIES; RESPIRATORY DISTRESS SYNDROME, NEWBORN; YOUNG ADULT;

EID: 84941097059     PISSN: 03005577     EISSN: 16193997     Source Type: Journal    
DOI: 10.1515/jpm-2014-0226     Document Type: Article

References (17)

1. Adkins B, Leclerc C, Marshall-Clarke S. Neonatal adaptive immunity comes of age. Nat Rev Immunol. 2004;4:553-64.
2. Christensen RD, Anstall HB, Rothstein G. Review: deficiencies in the neutrophil system of newborn infants, and the use of leukocyte transfusions in the treatment of neonatal sepsis. J Clin Apher. 1982;1:33-41.
3. Gentile LF, Nacionales DC, Lopez MC, Vanzant E, Cuenca A, Cuenca AG, et al. Protective immunity and defects in the neonatal and elderly immune response to sepsis. J Immunol. 2014 (epub ahead of print).
4. Kovarik J, Siegrist CA. Immunity in early life. Immunol Today. 1998;19:150-2.
5. Velilla PA, Rugeles MT, Chougnet CA. Defective antigenpresenting cell function in human neonates. Clin Immunol. 2006;121:251-9.
6. Andrews P, Azoulay E, Antonelli M, Brochard L, Brun-Buisson C, Dobb G, et al. Year in review in intensive care medicine, 2004. III. Outcome, ICU organisation, scoring, quality of life, ethics, psychological problems and communication in the ICU, immunity and hemodynamics during sepsis, pediatric and neonatal critical care, experimental studies. Intensive Care Med. 2005;31:356-72.
7. Hotchkiss RS, Monneret G, Payen D. Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy. Nat Rev Immunol. 2013;13:862-74.
8. Schefold JC, Hasper D, Reinke P, Monneret G, Volk HD. Consider delayed immunosuppression into the concept of sepsis. Crit Care Med. 2008;36:3118.
9. Schefold JC, Hasper D, Volk HD, Reinke P. Sepsis: time has come to focus on the later stages. Med Hypotheses. 2008;71:203-8.
10. Meisel C, Schwab JM, Prass K, Meisel A, Dirnagl U. Central nervous system injury-induced immune deficiency syndrome. Nat Rev Neurosci. 2005;6:775-86.
11. Meisel C, Schefold JC, Pschowski R, Baumann T, Hetzger K, Gregor J, et al. Granulocyte-macrophage colony-stimulating factor to reverse sepsis-associated immunosuppression: a double-blind, randomized, placebo-controlled multicenter trial. Am J Respir Crit Care Med. 2009;180:640-8.
12. Schefold JC, von Haehling S, Corsepius M, Pohle C, Kruschke P, Zuckermann H, et al. A novel selective extracorporeal intervention in sepsis: immunoadsorption of endotoxin, interleukin 6, and complement-activating product 5a. Shock. 2007;28:418-25.
13. Gladstone IM, Ehrenkranz RA, Edberg SC, Baltimore RS. A tenyear review of neonatal sepsis and comparison with the previous fifty-year experience. Pediatr Infect Dis J. 1990;9:819-25.
14. Hallwirth U, Pomberger G, Pollak A, Roth E, Spittler A. Monocyte switch in neonates: high phagocytic capacity and low HLADR expression in VLBWI are inverted during gestational aging. Pediatr Allergy Immunol. 2004;15:513-6.
15. Huang X, Venet F, Chung CS, Lomas-Neira J, Ayala A. Changes in dendritic cell function in the immune response to sepsis. Cell-& tissue-based therapy. Expert Opin Biol Ther. 2007;7:929-38.
16. Poehlmann H, Schefold JC, Zuckermann-Becker H, Volk HD, Meisel C. Phenotype changes and impaired function of dendritic cell subsets in patients with sepsis: a prospective observational analysis. Crit Care. 2009;13:R119.
17. Docke WD, Hoflich C, Davis KA, Rottgers K, Meisel C, Kiefer P, et al. Monitoring temporary immunodepression by flow cytometric measurement of monocytic HLA-DR expression: a multicenter standardized study. Clin Chem. 2005;51:2341-7.